Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Companies
  4. /
  5. Dipharma Inc., Kalamazoo, MI – FDA Inspections
Company
•United States

Dipharma Inc., Kalamazoo, MI – FDA Inspections

Inspection records and compliance data for Dipharma Inc. in Kalamazoo, Michigan. 1 FDA inspection on record, 1 Form 483, last inspected January 11, 2024.

Sign in to open in Dashboard
Company Profile

This profile covers Dipharma Inc. based in Kalamazoo, Michigan, United States.

FDA Inspection History

FDA inspections
1
OAI
0
VAI
0
NAI
0
Unclassified
1
Form 483s
1
Warning letters
0

Inspected January 11, 2024.

FDA inspections (1)

DateResultFDA center(s)Insp. #
January 11, 2024Not classifiedHuman Drugs1228260
FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

AbbVie Inc.
The Gillette Company
Apicore US LLC
SAFC Inc.
Pfizer Inc
Sterling Pharma USA LLC
Teva Branded Pharmaceutical Products R&D, LLC
Olon USA LLC
Pisgah Laboratories Inc
Allergan Sales, LLC dba Bioscience Laboratories
Company Information

Name

Dipharma Inc.

FEI Number

3004853226

Address

4502 Campus Drive, Kalamazoo, Michigan, United States

Country

United States

ID: 4811eaeb-9cc3-4956-88f1-d109b80aa86d

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.